Explore the full record of transactions filed by Lowenthal Richard E. Director active across 1 company, notably ARS Pharmaceuticals, Inc.. In total, 31 disclosures have been published. Breakdown: 0 buy · 26 sells. Total volume traded: €9.4m. Activity tracked since 17 May 2023. The latest transaction was disclosed on 21 August 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lowenthal Richard E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
An insider linked to ARS Pharmaceuticals, Inc., where the listed role is PRESIDENT AND CEO. He has 31 filings in total, and the 31 sampled filings run from 2022-11-10 to 2025-08-22, with EUR 0 of buys and EUR 9,357,144 of sells in the recent sample, and the modal transaction nature is Sale.